Neurocea Competitors and Similar CompaniesClear all
Rigel Pharmaceuticals's competitors and similar companies include Neopharm Boston and Terns Pharmaceuticals.
 Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  Neopharm Boston Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization. |  Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. | |
Founding Date | Founding Date 1996 | Founding Date 2007 | Founding Date 2017 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Marlborough, US HQ | Locations Foster City, US HQ |
Employees | Employees 1633% increase | Employees 717% increase | Employees 59 |
Valuation ($) | Valuation ($) 256 m | Valuation ($) N/A | Valuation ($) 580.9 m |
Financial | |||
Net income | Net income $367m (FY, 2025) | Net income N/A | Net income ($96.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 130m | Total funding raised N/A | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Neopharm Boston
HQ
Marlborough, US
Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization.
View companyTerns Pharmaceuticals
HQ
Foster City, US
Employees
59
Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases.
View company